期刊文献+

川崎病合并冠脉扩张危险因素分析 被引量:1

Analysis the Risk Factors of Kawasaki Disease Complicated with Coronary Artery Lesion
下载PDF
导出
摘要 目的:分析川崎病(KD)患儿出现冠状动脉扩张(CAL)的危险因素。方法:回顾性分析2007年~2011年我院86例住院KD患儿临床资料,对CAL组(n=18)和无冠状动脉扩张组(nCAL组,n=66)的一般资料、临床表现、实验室检查三类18项指标进行组间比较及Logistic回归分析。结果:(1)热程>10天、杨梅舌、血沉>100mm/h、C-反应蛋白(CRP)>100mg/L等4项指标两组间差异有统计学意义(P<0.05);(2)热程>10天(X1)的OR值为7.500(95%CI=1.023~54.996,P<0.05),KD发生CAL的危险因素主效应模型是logit(P)=β0(-0.693)+2.015X1(χ2=7.500,P<0.05)。结论:杨梅舌、血沉>100mm/h、CRP>100mg/L是KD患儿发生CAL的危险因素,热程>10天是KD患儿发生CAL的高危因素。 Objective: To investigate the risk factors of coronary artery lesion (CAL) caused by Kawasaki disease. Method: We retrospectively reviewed the clinical records of 86 patients with Kawasaki disease admitted to our department from 2007 to 2011, risk factors including general information,clinical manifestation and laboratory parameters total 18 factors were contrast between with CAL(n=18) and without coronary artery lesion patients(n=66) by case-control study and logistic regression analysis. Results: There were significant differences between patients with and without coronary artery involvement in the duration of fever, bayberry tongue, ESR and CRP. The results of logistic regression analysis indicated that the odds ratio of fever lasting over 10 days(X1) was 7.500(95% CI=1.023~54.996,P<0.05). The logistic regress equation of CAL risk factors was logit(P)=β0(-0.693)+2.015X1(χ2=7.500,P<0.05). Conclusion: Bayberry tongue, ESR>100 mm/h and CRP>100 mg/L are risk factors, long-lasting fever (>10d) is the high-risk factors of CAL in Kawasaki disease.
出处 《微循环学杂志》 2012年第3期32-33,36,共3页 Chinese Journal of Microcirculation
关键词 危险因素 川崎病 冠脉扩张 皮肤粘膜淋巴结综合征 冠状动脉扩张 血管炎综合征 自身免疫性 CAL Kawasaki disease Coronary artery lesion Risk factors Logistic models
  • 相关文献

参考文献13

  • 1Yashiro M,Uchara R,Oki I,et al.Yearly changes in gamma globulin treatment for Kawasaki disease patients,1999-2002[J].Nippon Shonika Gakkai Zasshi,2004,108 (12):1 461.
  • 2Ayuswa M,Sonober T,Uemura S,et al.Revision of diagnostic guidelines for Kawasaki disease(the 5th revised edition)[J].Pediatrint,2005,47(2):232-234.
  • 3胡亚美,江载芳,等,主编.诸福棠实用儿科学[M].第7版.北京:人民卫生出版社,2002.1 199.
  • 4Sabharwal T,Manlhiot C,Benseler SM,et al.Comparison of factors associated with coronary artery dilation only versus coronary artery aneurysms in patients with kawasaki diseasev[J].Am J Cardiol,2009,104(12):1 743-1 747.
  • 5Crystal MA,Manlhiot C,Yeung RS,et al.Coronary artery dilation after Kawasaki disease for children within the normal range[J].International Journal of Cardiology,2009,136(1):27-32.
  • 6段泓宇,华益民,王晓琴.川崎病患儿并发冠状动脉损害的高危因素分析[J].临床儿科杂志,2010,28(7):640-643. 被引量:27
  • 7Nakamura Y,Yashiro M,Sadakane A,et al.Six principal symptoms and coronary artery sequelae in Kawasaki disease[J].Pediatrics International,2009,51(5):705-708.
  • 8Newburger JW.Fulton DR.Kawasaki disease[J].Curr Opin Pediatr,2004,16(5):508-514.
  • 9刘亚黎.川崎病的冠状动脉损害[J].实用儿科临床杂志,2001,16(5):337-338. 被引量:64
  • 10陈艳丽,陈芸.川崎病患儿血沉、C-反应蛋白、D-二聚体测定与冠状动脉损伤的关系探讨[J].四川医学,2012,33(1):62-63. 被引量:10

二级参考文献50

  • 1陈兆鸿,刘特长,吕淑泓.川崎病并冠状动脉损害的危险因素[J].实用儿科临床杂志,2005,20(10):998-999. 被引量:10
  • 2王宏伟.川崎病并发心血管损害的若干问题[J].中国实用儿科杂志,2006,21(10):730-732. 被引量:47
  • 3赵立健,韩波.川崎病并冠状动脉损害研究进展[J].实用儿科临床杂志,2007,22(1):62-64. 被引量:27
  • 4孙景辉,翟淑波.川崎病发病机制研究进展[J].实用儿科临床杂志,2007,22(13):1037-1040. 被引量:27
  • 5川崎富作.指趾の特异的落屑を伴づ小兒の急性热性皮肤淋巴腺症候[J].つしルギ一,1967,(16):178.
  • 6[2]Laupland KD, Davies HD. Epidemiolog, etiology, and management of Kawasaki disease[ J ]. State of the Art Pediatr Cardiol, 1999; 20:177
  • 7[3]Fujiwara H, Hamashima Y. Pathology of the heart in Kawasaki disease[J]. Pediatrics, 1978;61:100
  • 8直江史郎,浅地聰,高桥啓.小兒の冠状動疾患一と<に冠状動瘤を中心にとして-[J].病理と臨床,1988,(6):184.
  • 9[5]Koto H,Sugimura T,Akagi T. Long-term consequences of Kawasaki disease. A 10-to 21-year follow-up strdy of 594 patients[J ]. Circulation, 1996 ; 94 : 1379
  • 10岩佐充二,失守信早昭,安藤恒三郎.川崎病の重症度の判定[J].小兒内科,1990,(12):61.

共引文献611

同被引文献11

  • 1杨世伟,王大为,秦玉明,王凤鸣,李军,胡正,张兰芳.人血丙种球蛋白对川崎病血清诱导血管内皮细胞表达基质金属蛋白酶-9的影响[J].实用儿科临床杂志,2005,20(3):223-225. 被引量:7
  • 2赵慧颖,徐宝华,马小欣.血清基质金属蛋白酶活性与动脉粥样硬化斑块稳定性的实验观察[J].中国微循环,2007,11(3):163-167. 被引量:16
  • 3孙景辉,翟淑波.川崎病发病机制研究进展[J].实用儿科临床杂志,2007,22(13):1037-1040. 被引量:27
  • 4杨锡强,易著文.儿科学[M].6版.北京:人民出版社,2005:360
  • 5Rowley AH, Shulman ST.Kawasaki disease.In : Behrman RE, Kliegma RM, Arivin AM.Nelson textbook of pediatrics[M]. 16^th.Philadelphia : W. B Saunders, 2000 : 725-727.
  • 6Senzaki H,Masutani S,Kobayashi J,et al.Circulating matrix metallo- proteinases and their inhibitors in patients with Kawasaki disease[J]. Circulation, 2001,104 ( 8 ) : 860-863.
  • 7Cheung YF, Yunf TC ,Tam SC, et al.Novel and traditional cardiovas- cular risk factors in children after Kawasaki disease:implications for premature atheroscleosis[J].J Am Coil Cardiol,2004,43 (1):120-124.
  • 8Japanese Circlulation Society Joint Research Group.Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease[J].Pediatr Int, 2005,47 (6) : 711-732.
  • 9Kanamaru H, Sato Y,Takayama T,et al.Assessment of coronary artery abnormalities by multislice spiral computed tomography in adoles- cents and young adults with Kawasaki disease[J].Am J Cardiol, 2005, 95(4) :522-525.
  • 10黄滢,吴柱国.川崎病发病机制的研究现状[J].广东医学院学报,2010,28(1):57-61. 被引量:9

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部